J Altern Complement Med 2013 May;19(5):459-463
Pre-Formulation Regulatory Risk Assessment (Gate) Before formula lock: Multi-country ingredient status mapping Claim limitation analysis (antioxidant / cellular protection / liver support not disease detox therapy) Liposomal delivery classification risk (novel excipient / Novel Food flags) Export documentation readiness (COA fields, specs, stability scope, labeling pack) Outcome: scientifically coherent, claim-safe, and commercially approvable architectures for the markets you actually intend to ship
Bottom line: This is the stack most likely to create confusion, wasted money, and avoidable risk
Use Proper Aseptic Technique: Proper storage is useless without proper handling
Subsequent studies and patents from the same group of researchers showed that a 15 amino acid peptide derived from the N-terminus of BPC, now known as BPC 157, has many of the same effects as the entire protein